MTOR and small cell lung carcinoma: RTN1, SPP1, CSMD3, and FST associated with neuroendocrine features, resistance to mTOR inhibitors, resistance to etoposide in SCLC, and a diagnostic biomarker of SCLC, respectively, were included (Table S2).9, 22, 23, 24